My Quote Request
No products added yet
6505-01-280-2318
20 Products
PIPRACIL
PIPERACILLIN SODIUM,USP
NSN, MFG P/N
6505012802318
NSN
6505-01-280-2318
MFG
AMERICAN CYANAMID CO LEDERLE LABORATORIES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 4.000 GRAMS PIPERACILLIN EQUIVALENT
ADMINISTRATION: INTRAMUSCULAR OR INTRAVENOUS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PIPERACILLIN SODIUM STERILE USP 4GM POWDER INTRAMUSCLAR/IV VIAL 10S
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 4.000 GRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
7651-03
HEPARIN SODIUM INJECTION,USP
NSN, MFG P/N
6505012799610
NSN
6505-01-279-9610
MFG
ABBOTT LABORATORIES INC. DIV HOSPITAL PRODUCTS DIVISION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 UNITS HEPARIN SODIUM PER MILLILITER
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: STERILE
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
RAW MATERIAL SOURCE: PORCINE INTESTINAL MUCOSA
SPECIAL FEATURES: NONPYROGENIC
Related Searches:
NDC00074-7651-03
HEPARIN SODIUM INJECTION,USP
NSN, MFG P/N
6505012799610
NSN
6505-01-279-9610
NDC00074-7651-03
HEPARIN SODIUM INJECTION,USP
NSN, MFG P/N
6505012799610
NSN
6505-01-279-9610
MFG
ABBOTT LABORATORIES INC. DIV HOSPITAL PRODUCTS DIVISION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 UNITS HEPARIN SODIUM PER MILLILITER
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: STERILE
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
RAW MATERIAL SOURCE: PORCINE INTESTINAL MUCOSA
SPECIAL FEATURES: NONPYROGENIC
Related Searches:
METRODIN
UROFOLLITROPIN FOR INJECTION
NSN, MFG P/N
6505012799623
NSN
6505-01-279-9623
METRODIN
UROFOLLITROPIN FOR INJECTION
NSN, MFG P/N
6505012799623
NSN
6505-01-279-9623
MFG
SERONO-BAKER DIAGNOSTICS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 75.000 INTERNATIONAL UNITS FOLLICLE-STIMULATING HORMONE ACTIVITY EQUIVALENT
ADMINISTRATION: INTRAMUSCULAR
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: UROFOLLITROPIN FOR INJECTION FREEZE-DRIED POWDER 75 I.U. AMPUL
PHYSICAL FORM: FREEZE-DRIED POWDER OR PELLET,STERILE
PRIMARY CONTAINER CONTENT QUANTITY: 75.000 INTERNATIONAL UNITS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: AMPUL
SPECIAL FEATURES: WITH ONE 2 ML AMPUL OF SODIUM CHLORIDE INJECTION,USP
Related Searches:
NDC44087-6075-01
UROFOLLITROPIN FOR INJECTION
NSN, MFG P/N
6505012799623
NSN
6505-01-279-9623
NDC44087-6075-01
UROFOLLITROPIN FOR INJECTION
NSN, MFG P/N
6505012799623
NSN
6505-01-279-9623
MFG
SERONO-BAKER DIAGNOSTICS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 75.000 INTERNATIONAL UNITS FOLLICLE-STIMULATING HORMONE ACTIVITY EQUIVALENT
ADMINISTRATION: INTRAMUSCULAR
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: UROFOLLITROPIN FOR INJECTION FREEZE-DRIED POWDER 75 I.U. AMPUL
PHYSICAL FORM: FREEZE-DRIED POWDER OR PELLET,STERILE
PRIMARY CONTAINER CONTENT QUANTITY: 75.000 INTERNATIONAL UNITS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: AMPUL
SPECIAL FEATURES: WITH ONE 2 ML AMPUL OF SODIUM CHLORIDE INJECTION,USP
Related Searches:
NDC44087-7075-03
UROFOLLITROPIN FOR INJECTION
NSN, MFG P/N
6505012799623
NSN
6505-01-279-9623
NDC44087-7075-03
UROFOLLITROPIN FOR INJECTION
NSN, MFG P/N
6505012799623
NSN
6505-01-279-9623
MFG
SERONO-BAKER DIAGNOSTICS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 75.000 INTERNATIONAL UNITS FOLLICLE-STIMULATING HORMONE ACTIVITY EQUIVALENT
ADMINISTRATION: INTRAMUSCULAR
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: UROFOLLITROPIN FOR INJECTION FREEZE-DRIED POWDER 75 I.U. AMPUL
PHYSICAL FORM: FREEZE-DRIED POWDER OR PELLET,STERILE
PRIMARY CONTAINER CONTENT QUANTITY: 75.000 INTERNATIONAL UNITS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: AMPUL
SPECIAL FEATURES: WITH ONE 2 ML AMPUL OF SODIUM CHLORIDE INJECTION,USP
Related Searches:
NDC54569-4528-00
UROFOLLITROPIN FOR INJECTION
NSN, MFG P/N
6505012799623
NSN
6505-01-279-9623
NDC54569-4528-00
UROFOLLITROPIN FOR INJECTION
NSN, MFG P/N
6505012799623
NSN
6505-01-279-9623
MFG
MERCK SHARP & DOHME CORP. D IV CORPORATE HEADQUARTERS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 75.000 INTERNATIONAL UNITS FOLLICLE-STIMULATING HORMONE ACTIVITY EQUIVALENT
ADMINISTRATION: INTRAMUSCULAR
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: UROFOLLITROPIN FOR INJECTION FREEZE-DRIED POWDER 75 I.U. AMPUL
PHYSICAL FORM: FREEZE-DRIED POWDER OR PELLET,STERILE
PRIMARY CONTAINER CONTENT QUANTITY: 75.000 INTERNATIONAL UNITS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: AMPUL
SPECIAL FEATURES: WITH ONE 2 ML AMPUL OF SODIUM CHLORIDE INJECTION,USP
Related Searches:
NDC00006-3552-59
IMIPENEM AND CILASTATIN FOR INJECTION,USP
NSN, MFG P/N
6505012799627
NSN
6505-01-279-9627
NDC00006-3552-59
IMIPENEM AND CILASTATIN FOR INJECTION,USP
NSN, MFG P/N
6505012799627
NSN
6505-01-279-9627
MFG
MERCK SHARP & DOHME CORP. DBA MERCK DIV US HUMAN HEALTH
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS CILASTATIN EQUIVALENT AND 500.000 MILLIGRAMS IMIPENEM EQUIVALENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: IMIPENEM & CILASTATIN SOD F/INJ SGL DOSE FI 1000MG 25S
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 MILLIGRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
SPECIAL FEATURES: 15 ML CAPACITY GLASS VIAL SHALL HAVE A DOUBLE LEAD SCREW THREAD DESIGNED TO INTERLOCK WITH THE INLET PORT OF THE FOLLOWING DILUENT CONTAINERS: 6505-01-260-1237,6505-01-260-1238,6505-01-260-1239,6505-01-260-1241,6505-01-260-1242; THE ASSEMBLY OF THE DRUG
TOTAL PRIMARY CONTAINER QUANTITY: 25
~1: VIAL AND DILUENT CONTAINER SHALL PROVIDE A TAMPER-RESISTANT,STERILE,LEAK PROOF BARRIER; EACH DRUG VIAL SHALL BE ENCLOSED IN AN UPPER AND LOWER PLASTIC SHROUD; THE UPPER SHROUD SHALL BE A STERILITY BARRIER WITH A PULL RING TO ALLOW EASE OF OPENING; THE
~2: LOWER SHROUD SHALL PROVIDE AN INTEGRAL HANGER TO SUPPORT THE ASSEMBLY AND ADMINISTRATION SET; THE VIAL SHALL HAVE A VIEWING PORT TO ALLOW CONFIRMATION OF DRUG ADDITION AND DISSOLUTION
Related Searches:
PRIMAXIN
IMIPENEM AND CILASTATIN FOR INJECTION,USP
NSN, MFG P/N
6505012799627
NSN
6505-01-279-9627
PRIMAXIN
IMIPENEM AND CILASTATIN FOR INJECTION,USP
NSN, MFG P/N
6505012799627
NSN
6505-01-279-9627
MFG
MERCK SHARP & DOHME CORP. DBA MERCK DIV US HUMAN HEALTH
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS CILASTATIN EQUIVALENT AND 500.000 MILLIGRAMS IMIPENEM EQUIVALENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: IMIPENEM & CILASTATIN SOD F/INJ SGL DOSE FI 1000MG 25S
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 MILLIGRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
SPECIAL FEATURES: 15 ML CAPACITY GLASS VIAL SHALL HAVE A DOUBLE LEAD SCREW THREAD DESIGNED TO INTERLOCK WITH THE INLET PORT OF THE FOLLOWING DILUENT CONTAINERS: 6505-01-260-1237,6505-01-260-1238,6505-01-260-1239,6505-01-260-1241,6505-01-260-1242; THE ASSEMBLY OF THE DRUG
TOTAL PRIMARY CONTAINER QUANTITY: 25
~1: VIAL AND DILUENT CONTAINER SHALL PROVIDE A TAMPER-RESISTANT,STERILE,LEAK PROOF BARRIER; EACH DRUG VIAL SHALL BE ENCLOSED IN AN UPPER AND LOWER PLASTIC SHROUD; THE UPPER SHROUD SHALL BE A STERILITY BARRIER WITH A PULL RING TO ALLOW EASE OF OPENING; THE
~2: LOWER SHROUD SHALL PROVIDE AN INTEGRAL HANGER TO SUPPORT THE ASSEMBLY AND ADMINISTRATION SET; THE VIAL SHALL HAVE A VIEWING PORT TO ALLOW CONFIRMATION OF DRUG ADDITION AND DISSOLUTION
Related Searches:
01420
GENTAMICIN SULFATE INJECTION,USP
NSN, MFG P/N
6505012800050
NSN
6505-01-280-0050
01420
GENTAMICIN SULFATE INJECTION,USP
NSN, MFG P/N
6505012800050
NSN
6505-01-280-0050
MFG
SOLOPAK MEDICAL PRODUCTS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 40.000 MILLIGRAMS GENTAMICIN SULFATE PER MILLILITER
ADMINISTRATION: INTRAMUSCULAR
PRIMARY CONTAINER CONTENT QUANTITY: 20.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, MULTIPLE DOSE
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
NDC39769-0014-20
GENTAMICIN SULFATE INJECTION,USP
NSN, MFG P/N
6505012800050
NSN
6505-01-280-0050
NDC39769-0014-20
GENTAMICIN SULFATE INJECTION,USP
NSN, MFG P/N
6505012800050
NSN
6505-01-280-0050
MFG
SOLOPAK MEDICAL PRODUCTS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 40.000 MILLIGRAMS GENTAMICIN SULFATE PER MILLILITER
ADMINISTRATION: INTRAMUSCULAR
PRIMARY CONTAINER CONTENT QUANTITY: 20.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, MULTIPLE DOSE
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
NDC00004-1998-06
MIDAZOLAM HYDROCHLORIDE INJECTION
NSN, MFG P/N
6505012801074
NSN
6505-01-280-1074
NDC00004-1998-06
MIDAZOLAM HYDROCHLORIDE INJECTION
NSN, MFG P/N
6505012801074
NSN
6505-01-280-1074
MFG
HOFFMANN-LA ROCHE INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 MILLIGRAM MIDAZOLAM EQUIVALENT PER MILLILITER
ADMINISTRATION: INTRAMUSCULAR OR INTRAVENOUS
FEATURES PROVIDED: STERILE
III CONTROLLED SUBSTANCE CLASSIFICATION: SCHEDULE IV
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MIDAZOLAM HYDROCHLORIDE INJECTION 1MG EQUIV PER ML IV 2ML VIAL 10S
III PROTECTIVE STORAGE FEATURE: SECURITY STORAGE
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00074-2587-02
MIDAZOLAM HYDROCHLORIDE INJECTION
NSN, MFG P/N
6505012801074
NSN
6505-01-280-1074
NDC00074-2587-02
MIDAZOLAM HYDROCHLORIDE INJECTION
NSN, MFG P/N
6505012801074
NSN
6505-01-280-1074
MFG
ABBOTT LABORATORIES INC. DIV HOSPITAL PRODUCTS DIVISION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 MILLIGRAM MIDAZOLAM EQUIVALENT PER MILLILITER
ADMINISTRATION: INTRAMUSCULAR OR INTRAVENOUS
FEATURES PROVIDED: STERILE
III CONTROLLED SUBSTANCE CLASSIFICATION: SCHEDULE IV
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MIDAZOLAM HYDROCHLORIDE INJECTION 1MG EQUIV PER ML IV 2ML VIAL 10S
III PROTECTIVE STORAGE FEATURE: SECURITY STORAGE
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC55390-0137-02
MIDAZOLAM HYDROCHLORIDE INJECTION
NSN, MFG P/N
6505012801074
NSN
6505-01-280-1074
NDC55390-0137-02
MIDAZOLAM HYDROCHLORIDE INJECTION
NSN, MFG P/N
6505012801074
NSN
6505-01-280-1074
MFG
BEN VENUE LABORATORIES INC DBA BEDFORD LABORATORIES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 MILLIGRAM MIDAZOLAM EQUIVALENT PER MILLILITER
ADMINISTRATION: INTRAMUSCULAR OR INTRAVENOUS
FEATURES PROVIDED: STERILE
III CONTROLLED SUBSTANCE CLASSIFICATION: SCHEDULE IV
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MIDAZOLAM HYDROCHLORIDE INJECTION 1MG EQUIV PER ML IV 2ML VIAL 10S
III PROTECTIVE STORAGE FEATURE: SECURITY STORAGE
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
VERSED
MIDAZOLAM HYDROCHLORIDE INJECTION
NSN, MFG P/N
6505012801074
NSN
6505-01-280-1074
VERSED
MIDAZOLAM HYDROCHLORIDE INJECTION
NSN, MFG P/N
6505012801074
NSN
6505-01-280-1074
MFG
HOFFMANN-LA ROCHE INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 MILLIGRAM MIDAZOLAM EQUIVALENT PER MILLILITER
ADMINISTRATION: INTRAMUSCULAR OR INTRAVENOUS
FEATURES PROVIDED: STERILE
III CONTROLLED SUBSTANCE CLASSIFICATION: SCHEDULE IV
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MIDAZOLAM HYDROCHLORIDE INJECTION 1MG EQUIV PER ML IV 2ML VIAL 10S
III PROTECTIVE STORAGE FEATURE: SECURITY STORAGE
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
013572
ASPIRIN,ALUMINUM HYDROXIDE GEL,DRIED,CALCIUM CARBONATE,AND MAGNESIUM HYDROXIDE TABLETS
NSN, MFG P/N
6505012801793
NSN
6505-01-280-1793
013572
ASPIRIN,ALUMINUM HYDROXIDE GEL,DRIED,CALCIUM CARBONATE,AND MAGNESIUM HYDROXIDE TABLETS
NSN, MFG P/N
6505012801793
NSN
6505-01-280-1793
MFG
AVENTIS PHARMACEUTICALS PRODUCTS INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS ALUMINUM HYDROXIDE GEL, DRIED ACTIVE INGREDIENT AND 50.000 MILLIGRAMS MAGNESIUM HYDROXIDE ACTIVE INGREDIENT AND 87.000 MILLIGRAMS CALCIUM CARBONATE ACTIVE INGREDIENT AND 325.000 MILLIGRAMS ASPIRIN ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 TABLETS
SPECIAL FEATURES: PRIMARY CONTAINER TYPE:PACKET;
TOTAL PRIMARY CONTAINER QUANTITY: 250
Related Searches:
ASCRIPTIN
ASPIRIN,ALUMINUM HYDROXIDE GEL,DRIED,CALCIUM CARBONATE,AND MAGNESIUM HYDROXIDE TABLETS
NSN, MFG P/N
6505012801793
NSN
6505-01-280-1793
ASCRIPTIN
ASPIRIN,ALUMINUM HYDROXIDE GEL,DRIED,CALCIUM CARBONATE,AND MAGNESIUM HYDROXIDE TABLETS
NSN, MFG P/N
6505012801793
NSN
6505-01-280-1793
MFG
AVENTIS PHARMACEUTICALS PRODUCTS INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS ALUMINUM HYDROXIDE GEL, DRIED ACTIVE INGREDIENT AND 50.000 MILLIGRAMS MAGNESIUM HYDROXIDE ACTIVE INGREDIENT AND 87.000 MILLIGRAMS CALCIUM CARBONATE ACTIVE INGREDIENT AND 325.000 MILLIGRAMS ASPIRIN ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 TABLETS
SPECIAL FEATURES: PRIMARY CONTAINER TYPE:PACKET;
TOTAL PRIMARY CONTAINER QUANTITY: 250
Related Searches:
NDC00067-0145-72
ASPIRIN,ALUMINUM HYDROXIDE GEL,DRIED,CALCIUM CARBONATE,AND MAGNESIUM HYDROXIDE TABLETS
NSN, MFG P/N
6505012801793
NSN
6505-01-280-1793
NDC00067-0145-72
ASPIRIN,ALUMINUM HYDROXIDE GEL,DRIED,CALCIUM CARBONATE,AND MAGNESIUM HYDROXIDE TABLETS
NSN, MFG P/N
6505012801793
NSN
6505-01-280-1793
MFG
AVENTIS PHARMACEUTICALS PRODUCTS INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS ALUMINUM HYDROXIDE GEL, DRIED ACTIVE INGREDIENT AND 50.000 MILLIGRAMS MAGNESIUM HYDROXIDE ACTIVE INGREDIENT AND 87.000 MILLIGRAMS CALCIUM CARBONATE ACTIVE INGREDIENT AND 325.000 MILLIGRAMS ASPIRIN ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 TABLETS
SPECIAL FEATURES: PRIMARY CONTAINER TYPE:PACKET;
TOTAL PRIMARY CONTAINER QUANTITY: 250
Related Searches:
NDC00378-0205-01
AMOXICILLIN CAPSULES,USP
NSN, MFG P/N
6505012802162
NSN
6505-01-280-2162
NDC00378-0205-01
AMOXICILLIN CAPSULES,USP
NSN, MFG P/N
6505012802162
NSN
6505-01-280-2162
MFG
MYLAN PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS AMOXICILLIN ACTIVE INGREDIENT
ADMINISTRATION: ORAL
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00206-3880-25
PIPERACILLIN SODIUM,USP
NSN, MFG P/N
6505012802318
NSN
6505-01-280-2318
NDC00206-3880-25
PIPERACILLIN SODIUM,USP
NSN, MFG P/N
6505012802318
NSN
6505-01-280-2318
MFG
AMERICAN CYANAMID CO LEDERLE LABORATORIES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 4.000 GRAMS PIPERACILLIN EQUIVALENT
ADMINISTRATION: INTRAMUSCULAR OR INTRAVENOUS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PIPERACILLIN SODIUM STERILE USP 4GM POWDER INTRAMUSCLAR/IV VIAL 10S
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 4.000 GRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 10
